Provided by Tiger Trade Technology Pte. Ltd.

Biohaven Pharmaceutical Holding Co Ltd.

13.85
+0.35002.59%
Post-market: 13.860.0081+0.06%19:56 EDT
Volume:2.09M
Turnover:29.33M
Market Cap:2.08B
PE:-3.09
High:14.33
Open:13.60
Low:13.53
Close:13.50
52wk High:18.57
52wk Low:7.48
Shares:150.42M
Float Shares:117.99M
Volume Ratio:0.94
T/O Rate:1.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4800
EPS(LYR):-6.8648
ROE:-799.46%
ROA:-71.98%
PB:170.45
PE(LYR):-2.02

Loading ...

Biohaven Files Form 3 Initial Beneficial Ownership Statement for Director John Yetimoglu

Reuters
·
Aug 15

Biohaven Supported by Multiple Pipeline Catalysts, Cash Runway Into 2027, RBC Says

MT Newswires Live
·
Aug 11

RBC Adjusts Price Target on Biohaven to $23 From $22, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 11

Bank of America Securities Reaffirms Their Buy Rating on Biohaven Ltd. (BHVN)

TIPRANKS
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Arcutis Biotherapeutics (ARQT) and Biohaven Ltd. (BHVN)

TIPRANKS
·
Aug 11

Biohaven Q2 Adj. EPS $(0.78) Misses $(0.73) Estimate

Benzinga Earnings
·
Aug 11

Biohaven Ltd. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Biohaven Q2 Adjusted Loss Narrows

MT Newswires Live
·
Aug 11

Biohaven Q2 Net Loss Narrows on Lower R&D Spend

Reuters
·
Aug 11

Biohaven Q2 FY26 Net Loss Narrows 30.7% to $137.31 Million; R&D Expenses Fall 45.34% to $100.81 Million

Reuters
·
Aug 11

Biohaven Q2 Basic EPS USD -0.91

THOMSON REUTERS
·
Aug 11

Biohaven Appoints John Yetimoglu to Board

Reuters
·
Aug 08

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jul 31

How Biohaven’s (BHVN) Trade Secret Verdict Shapes Its Intellectual Property Defense Strategy

Simply Wall St.
·
Jul 28

Biohaven Awarded $1 Million Over Alleged Trade Secret Violations by Avilar Therapeutics, RA Capital Management

MT Newswires Live
·
Jul 27

Biohaven, Yale Win USD 4 Million Jury Verdict over MODA Trade Secret Theft

Reuters
·
Jul 27

Biohaven reports new data on BHV-1530

TIPRANKS
·
Jul 20

Biohaven enters into clinical supply agreement with Regeneron

TIPRANKS
·
Jul 20

Biohaven Signs Regeneron Supply Deal to Test Bhv-1530 with Libtayo

Reuters
·
Jul 20

Biohaven to Present New Clinical Data at Esmo Congress on Bhv-1530, a Novel Fgfr3-directed ADC with a Proprietary Topoisomerase I (topoix) Payload

THOMSON REUTERS
·
Jul 20